申请人:Apeiron Biologicals AG
公开号:US20150353910A1
公开(公告)日:2015-12-10
The present invention relates to modified angiotensin converting enzyme 2 (ACE2) polypeptides and pharmaceutical and analytical uses thereof. In particular, the present invention relates to Zn
2+
depleted-, Zn
2+
free-, mixed metal- and metal ion substituted-ACE2 as well as methods for the manufacture of these variants and uses thereof, such as therapeutic and analytic uses of these ACE2 variants.